Collaboration - June 24, 2026
Iconovo and Lonza sign collaboration agreement
The agreement, building on a letter of intent announced earlier this year, is intended to establish a long-term partnership in spray-dried formulations, a technology considered important for the development of inhalable drug formulations for biologics, vaccines, and other large molecules.
Acquisition - June 15, 2026
Pelago Bioscience acquires RG Discovery
By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization, the company states.
Pharma article - June 10, 2026
Nose to nose with the future of drug delivery
Once limited to decongestants, nasal drug delivery is emerging as one of medicine’s most promising frontiers, offering faster uptake, stronger immunity, and the potential to block transmission before disease takes hold.
In a new job - June 9, 2026
Orexo strengthens its business development efforts
The company is strengthening its focus on new partnerships through the appointment of Raheleh Nassaji as Senior Vice President Business Development.
Agreement - June 9, 2026
AlzeCure Pharma enters collaboration and out-licensing agreement with Lilly
AlzeCure Pharma has entered into a collaboration and out-licensing agreement with the pharmaceutical company Eli Lilly and Company regarding the global rights to the Alzheimer’s project Alzstatin ACD680.
Collaboration - June 8, 2026
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China
Moberg Pharma has entered into a license agreement with Karo Healthcare regarding the commercialization of the nail fungus drug MOB-015 (Terclara) in China through the rapidly growing cross-border e-commerce channel.
